AndreaBozzo/ceres-open-data-index huggingface dataset:
NSDUH 2022 Sample Design Report

Learn about the sample design used for the 2022 National Survey on Drug Use and Health (NSDUH). The report describes the five stages of sample selection, sample weighting and variance estimation procedures, and the impact of the coronavirus disease 2019 (COVID-19) pandemic on sampling.Chapters:Introduces the report, describes the target population, provides a general overview of the 2022 NSDUH sample design, and summarizes the impact of the COVID-19 pandemic on the 2022 NSDUH.Summarizes the 2014 through 2022 coordinated sample design.Discusses the first three stages of selection in greater detail.Describes the 2022 NSDUH hybrid field enumeration and address-based sampling frameDiscusses the fourth and fifth stages of selection.Describes sample weighting and variance estimation procedures for 2022.Summarizes the sample design for the Incentives Field Test
Elk Creek Seismic Waveforms 2011 (Part 6 of 19)

Coal bursts (damaging seismic events in underground coal mines) pose a substantial threat to operations and mine workers. The underground coal mines in Colorado’s North Fork Valley (NFV) have experienced many coal bursts, often with distinct characteristics from those of other US coal mining regions. To better understand these events and manage their associated risks, the National Institute for Occupational Safety and Health undertook a long-term monitoring campaign at the Elk Creek Mine in the NFV. The monitoring efforts included a seismic network composed of both surface and underground sensors, borehole pressure cells (BPCs), instrumented support Cans, convergence monitors, ground condition surveys, and several other data sources. This dataset consists of the event waveform files from the seismic network for the 983,379 events that were detected during the monitoring campaign. The waveforms are stored in HDF5 files that are broken up by week. Within the HDF5 files, the data are organized by station id, event time, and channel. The amplitudes are velocity in meters/second.
 
This is download 14 of 48 and corresponds to the time range between February 7, 2011, and February 14, 2011.
Patent AT-E400170-T1: [Translated] TOWED AGRICULTURAL DISTRIBUTION MACHINE

A tractor-drawn agricultural spray-trailer has a tank and spreader arms resting on a chassis (1). The trailer is pulled by a draw-bar (3) linked to the chassis by a pin (7) which is transverse to the direction of travel. The draw bar and chassis are linked esp. by a length-adjustable hydraulic arm (9), by means of which the drawbar arm end-height is adjustable.
Loperamide hydrochloride

Imodium A-D is an over-the-counter medication containing loperamide hydrochloride, used to relieve symptoms of diarrhea in adults and children over 6 years old. It comes as an oral solution (1 mg per 7.5 mL) and works by slowing intestinal movement. Take as directed; consult a doctor if symptoms persist or worsen. This information was generated using AI and is provided for informational and research purposes only.
Compound 528927: Benzaldehyde, 2-hydroxy, 3-nitro-5-tert.-octyl, oxime, TMS

Chemical compound data from PubChem database. IUPAC Name: 1-(5-tert-butyl-3-nitro-2-trimethylsilyloxyphenyl)-N-trimethylsilyloxymethanimine. Molecular Formula: C17H30N2O4Si2. Molecular Weight: 382.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
COVID-19 State Profile Report - Florida

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 525185: Tetrapropylene glycol, monoallyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 1-[1-[1-(1-prop-2-enoxypropan-2-yloxy)propan-2-yloxy]propan-2-yloxy]propan-2-yl acetate. Molecular Formula: C17H32O6. Molecular Weight: 332.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529798: N-Methoxy-N-methyl-4-indanecarboxamide

Chemical compound data from PubChem database. IUPAC Name: propan-2-yl 2-[(2,2,2-trifluoroacetyl)amino]pentanoate. Molecular Formula: C10H16F3NO3. Molecular Weight: 255.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526362: 4,6-Dibromodibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 4,6-dibromodibenzofuran. Molecular Formula: C12H6Br2O. Molecular Weight: 325.98. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E40143-T1: [Translated] PROCESS FOR MAKING SHAPED NYLON BLOCK POLYMERS.

A process for preparing a molded nylon block copolymer, which comprises (A) bringing into reactive admixture a lactam monomer, a basic lactam polymerization catalyst and a composition containing a lactam functional material selected from those of the formulae: <CHEM>  wherein; Q is   -N@C=O, with Y equal to C3-C11 alkylene;  b is an integer equal to 2 or more; R is an alkyl, aryl, aralkyl, alkyloxy, aryloxy, aralkyloxy or Q group;  Z is a segment of: (1) a polyether, provided said polyether is not solely polyarylene polyether; (2) a polyester containing polyether or polymeric hydrocarbon segments;  (3) a hydrocarbon;  (4) a polysiloxane; or  (5) mixtures thereof, and (B) allowing the admixture to polymerize in a mold.
AFCARS Report #29

This report provides preliminary estimates of Adoption and Foster Care Analysis and Reporting System (AFCARS) data for FY 2021. As states are permitted to resubmit AFCARS data, the estimates may change over time. This report reflects all AFCARS data received as of June 28, 2022 related to AFCARS reporting periods through September 30, 2021.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 525692: p-Chlorobenzylidene-propyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-chlorophenyl)-N-propylmethanimine. Molecular Formula: C10H12ClN. Molecular Weight: 181.66. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
The dominance of the population by a selected few: power-law behaviour applies to a wide variety of genomic properties

The sequencing of genomes provides us with an inventory of the 'molecular parts' in nature, such as protein families and folds, and their functions in living organisms. The genomic occurrence of generalized parts follows a well-known mathematical framework called the power law, with a few parts occurring many times and most occurring only a few times. Cases of power-law behavior, were found, for example in the occurrence of pseudogenes and in levels of gene expression.
2015 CMHS Uniform Reporting System (URS) Table for Connecticut

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Connecticut. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E400461-T1: [Translated] METHOD FOR PRODUCING A SEALING OR DECORATIVE STRIP, PARTICULARLY FOR A MOTOR VEHICLE, AND SUCH A SEALING OR DECORATIVE STRIP

The invention relates to a method for producing a sealing or decorative strip, in particular, for a motor vehicle (10), said strip comprising a first component (20) and a second component (30) which are adjacent on the front side. Said method comprises the steps of a) extruding a first component (20), made of a first material, b) providing the first component (20) with an end section (21), having an upper side (22), a lower side (23) and a front side (24), c) providing the end section (21) with a cavity (25) which extends inside the first component (20) and opens on the front side (24), d) injection moulding the second component (30) by means of a moulding mass, made of a second material, whereby, during injection moulding, the first and second components are joined by a material fit on the front side and the moulding mass enters the cavity. Preferably, the first and second components are respectively embodied as a seal (20) and an end cap (30), terminating the seal (20) at the end section (21).
Patent AT-E40065-T1: [Translated] VIBRATION FINISHING MACHINE.

1. A vibrating grinding machine with a container (1) for receiving the mass to be vibrated and a generator of vibrations (2), characterized in that the container (1) comprises at the bottom (3, 3') a discharge device (14) for the mass to be vibrated, on which is disposed a free internal jacket (10), the bottom being concave, convex or flat-shaped in the region of the discharge device.
Methotrexate

Methotrexate Sodium is a generic injectable medication used to treat certain cancers, rheumatoid arthritis, and other conditions by interfering with cell growth. Available as preservative-free solutions in strengths like 50mg/2mL, 100mg/4mL, 200mg/8mL, and 250mg/10mL, administered via intramuscular, intrathecal, intravenous, or subcutaneous routes. Manufactured by Eugia US LLC under ANDA201529. This information was generated using AI and is provided for informational and research purposes only.
2021 Methodological Summary And Definitions

Use this summary report to properly interpret 2021 NSDUH estimates of substance use and mental health issues. The report accompanies theannual detailed tablesand covers overall methodology, key definitions for measures and terms used in 2021 NSDUH reports and tables, and selected analyses of the measures and how they should be interpreted.The report is organized into six chapters:Introduction.Description of the survey, including information about the sample design, data collection procedures, and key aspects of data processing such as development of the analysis weights. The report also includes methodological changes and related issues in the 2021 NSDUH due to COVID-19.Technical details on the statistical methods and measurement, such as suppression criteria for unreliable estimates, statistical testing procedures, issues around selected substance use and mental health measures, and the impact of methodological changes on response rates.Special topics related to prescription psychotherapeutic drugs.A comparison between NSDUH and other sources of data on substance use and mental health issues, including data sources for populations outside the NSDUH target population.A more in-depth view of special methodological issues for the 2021 NSDUH, including the results of special analyses that led SAMHSA to not compare estimates from 2021 to estimates from previous years.An appendix covers key definitions used in NSDUH reports and tables.
NNDSS - Table II. Giardiasis to Haemophilus influenza

NNDSS - Table II. Giardiasis to Haemophilus influenza - 2017.  In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed. The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories.

Note:
These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. 

Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. 

Footnotes:
 C.N.M.I.: Commonwealth of Northern Mariana Islands. 

U: Unavailable. —: No reported cases. N: Not reportable. NN: Not Nationally Notifiable. NP: Nationally notifiable but not published. Cum: Cumulative year-to-date counts. Med: Median. Max: Maximum. 

*Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verification with reporting jurisdictions. 

† Case counts for reporting year 2017 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for tuberculosis are displayed in Table IV, which appears quarterly.

§ Data for Haemophilus influenzae (age <5 for serotype b, nontypeable, non-b serotype, and unknown serotype) are available in Table I.
Massachusetts 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Patent AT-E401552-T1: [Translated] POSITION MEASURING DEVICE AND METHOD FOR OPERATING A POSITION MEASURING DEVICE

A position measuring device having a scanning element assigned to a periodic measuring graduation, the scanning element moves relative to the measuring graduation so as to scan the measuring graduation and generates a first analog signal and a second analog signal that is phase shifted relative to the first analog signal. A module that forms a measured position value, wherein the first and second analog signals are present at the module, and a code word defines a position that is present at an output of the module. An output module that digitally outputs the code word over a data channel and a conversion device that converts the first analog signal and the second analog signal into multi-digit amplitude-proportional code words, wherein the code words are also available at the output module for outputting on the data channel and is digitally transmitted by the output module over the data channel.
Compound 525817: N-Phenyl-N'-(3-methylphenyl)formamidine

Chemical compound data from PubChem database. IUPAC Name: N-(3-methylphenyl)-N'-phenylmethanimidamide. Molecular Formula: C14H14N2. Molecular Weight: 210.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child Welfare Then and Now

This Child Welfare Information Gateway Podcast is available on Apple Podcasts
  
  

, GooglePlay
  
  

, Spotify
  
  

, Stitcher
  
  

, SoundCloud
  
  

, and the Child Welfare Information Gateway
  
  

 website. Subscribe to receive new episodes as they are released.

Metadata-only record linking to the original dataset. Open original dataset below.
NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute

NNDSS - TABLE 1P. Hemolytic uremic syndrome post-diarrheal to Hepatitis B, acute - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Census tracts with no Well Water Index (WWI) assigned

The WWI is a screening tool that uses nationally available datasets to summarize baseline characteristics about weather-related hazards and vulnerability at the census tract level for communities reliant on private wells. This dataset contains continental US census tracts for which no WWI was created due to less than 1 estimated person being on well water in the census tract. To visualize these data, please visit the Tracking Network at https://ephtracking.cdc.gov/DataExplorer/. For a lay description of these data, please visit https://ephtracking.cdc.gov/indicatorPages and for the scientific publication detailing these data please visit https://pubmed.ncbi.nlm.nih.gov/39510280/

The data for the nationally-normed WWI can be accessed here https://data.cdc.gov/dataset/Nationally-normed-WWI/fxwg-3udm/about_data.

The data for the state-normed WWI can be accessed here
https://data.cdc.gov/dataset/State-Normed-WWI/snkv-n8f6/about_data
Patent AT-E400941-T1: [Translated] CONFIGURATION OF AN ENCRYPTION KEY IN THE WIFI ACCESS POINT AND IN THE TERMINAL

An object of the present invention is to enable the configuration tasks needed to form a wireless LAN to be performed using a simple method while increasing security during such configuration. In a wireless network configuration system (GH1) including an encryption key setting system (LH1), where an access point (20) determines after the power thereto is turned ON that configuration for connection to a wireless LAN has not yet be carried out, the access point (20) activates a restricted receiving mode in which only an initial configuration packet is accepted. A terminal (50) that has sent an initial configuration packet and the access point (20) that has received such initial configuration packet while the restricted receiving mode is active each create an identical WEP key with reference to the data on a CD-ROM (51) or the data in a ROM (12), respectively, and set and register the created WEP key in itself. <IMAGE>
A comparison of hospital readmission rates between two general physicians with different outpatient review practices

Background
          There has been a relentless increase in emergency medical admissions in the UK over recent years. Many of these patients suffer with chronic conditions requiring continuing medical attention. We wished to determine whether conventional outpatient clinic follow up after discharge has any impact on the rate of readmission to hospital.
        
        
          Methods
          Two consultant general physicians with the same patient case-mix but markedly different outpatient follow-up practice were chosen. Of 1203 patients discharged, one consultant saw twice as many patients in the follow-up clinic than the other (Dr A 9.8% v Dr B 19.6%). The readmission rate in the twelve months following discharge was compared in a retrospective analysis of hospital activity data. Due to the specialisation of the admitting system, patients mainly had cardiovascular or cerebrovascular disease or had taken an overdose. Few had respiratory or infectious diseases. Outpatient follow-up was focussed on patients with cardiac disease.
        
        
          Results
          Risk of readmission increased significantly with age and length of stay of the original episode and was less for digestive system and musculo-skeletal disorders. 28.7% of patients discharged by Dr A and 31.5 % of those discharged by Dr B were readmitted at least once. Relative readmission risk was not significantly different between the consultants and there was no difference in the length of stay of readmissions.
        
        
          Conclusions
          Increasing the proportion of patients with this age- and case-mix who are followed up in a hospital general medical outpatient clinic is unlikely to reduce the demand for acute hospital beds.